or
forgot password
  • cancer clinical trials in birmingham, AL

  • Comparing Peripheral Blood Stem Cell Transplantation Versus Bone Marrow Transplantation in Individuals With Hematologic Cancers
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Leukemia, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases
    Stem Cell Transplantation in Individuals With Multiple Myeloma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Multiple Myeloma
    Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Lung Cancer, Pulmonary Complications, Radiation Fibrosis
    CA-125 in Screening Patients at High Risk for Ovarian Cancer
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Ovarian Cancer
    Study of Late-Occurring Complications in Childhood Cancer Survivors
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Cancer Survivor, Cardiovascular Complications, Hematopoietic/Lymphoid Cancer, Unspecified Childhood Solid Tumor, Protocol Specific
    Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
    UAB Comprehensive Cancer Center-LNB 301
    Birmingham, Alabama 35294-0111
    Breast Cancer
    Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    brca1 Mutation Carrier, brca2 Mutation Carrier, Ovarian Cancer
    Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
    Children's Hospital of Alabama at University of Alabama at Birmingham
    Birmingham, Alabama 35233
    Brain Tumor, Central Nervous System Tumor
    DNA Variations in the Gene in Young Patients With Wilms' Tumor
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Kidney Cancer
    Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Breast Cancer
    Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Bladder Cancer
    Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Breast Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Leukemia
    Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
    University of Alabama Arthritis Intervention Program (Adult Site)
    Birmingham, Alabama 35294
    Myositis, Dermatomyositis, Polymyositis, Juvenile Dermatomyositis
    Study of REN-1654 in Patients With Sciatica Pain
    Alabama Clinical Therapeutics
    Birmingham, Alabama 35235
    Sciatica, Herniated Disc, Radiculopathy
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Malignant Glioma, Glioblastoma Multiforme, GBM, Anaplastic Astrocytoma, Oligo-Astrocytoma, Gliosarcoma
    Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Myeloid Leukemia, Chronic, Chronic-Phase
    Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Myeloid Leukemia, Chronic, Accelerated Phase, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
    Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Liver Cancer
    Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
    VA Medical Center, Birmingham
    Birmingham, Alabama 35233
    Prostate Cancer
    Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Localized Osteosarcoma, Metastatic Osteosarcoma
    Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)
    Birmingham Hematology and Oncology Associates, LLC
    Birmingham, Alabama 35235
    Carcinoma, Non-Small-Cell Lung, Non-small Cell Lung Cancer, NSCLC
    Study of Long-Term Peg Intron Vs. Colchicine in Non-Responders.
    Birmingham Gastroenterology Associates
    Birmingham, Alabama 35209
    Hepatitis C Virus, Advanced Fibrosis, Cirrhosis
    A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma
    Birmingham Hematology and Oncology
    Birmingham, Alabama 35235
    Lymphoma, T-Cell, Peripheral
    Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Cervical Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Cetuximab With or Without Carboplatin in Treating Women With Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Breast Cancer
    Radiation Therapy in Treating Young Patients With Gliomas
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Brain Tumor, Central Nervous System Tumor
    Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass
    Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham
    Birmingham, Alabama 35294
    Fallopian Tube Cancer, Ovarian Cancer
    PhII ICb With/Without Erbitux in MBC Pts
    Birmingham Hematology and Oncology
    Birmingham, Alabama 35235
    Metastatic Breast Cancer
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Head and Neck Cancer
    Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Leukemia
    Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Stage I Adrenocortical Carcinoma, Stage II Adrenocortical Carcinoma, Stage III Adrenocortical Carcinoma, Stage IV Adrenocortical Carcinoma
    TOMUS-Trial Of Mid-Urethral Slings
    University of Alabama
    Birmingham, Alabama
    Urinary Incontinence
    AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Neurofibromatosis Type 1, Plexiform Neurofibroma, Spinal Cord Neurofibroma
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
    Children's Hospital of Alabama at University of Alabama at Birmingham
    Birmingham, Alabama 35233
    Kidney Cancer
    Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Untreated Childhood Medulloblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Childhood Malignant Mesenchymoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Adult Brain Tumor, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Stage III Wilms Tumor, Stage IV Wilms Tumor
    Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Untreated Childhood Medulloblastoma, Untreated Childhood Pineoblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor